Natalya Yu. Shagina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalya Yu. Shagina has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Olga Arkadievna Obukhova
Peoples' Friendship University of Russia
5 shared publications - Ildar Anvarovich Kurmukov
Peoples' Friendship University of Russia
4 shared publications - Dimitar T. Marinov
Blokhin National Medical Research Center of Oncology
2 shared publications - Mariya S. Trifonova
N.N. Blokhin National Medical Research Center of Oncology
2 shared publications - A. O. Addai
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Anastasia Sergeevna Ivanova
State Scientific Centre of Coloproctology
1 shared publication
Latest Publications
- 17 November 2026
- Published by Alfmed LLC in Medical alphabet
- No. 27
A comparative analysis of the key clinical, morphological, and diagnostic characteristics of triple-negative breast cancer in Ghanaian and Russian female populations
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that disproportionately affects women of African descent. In Ghana, the frequency of TNBC is 49%. African-American women with TNBC have worse clinical outcomes than women of European descent. Differences in healthcare systems, access to modern diagnostic and treatment methods, as well as the country of residence at the time of diagnosis, may influence treatment strategy and survival rates. Objective. To analyze the clinical and morphological characteristics of TNBC in Ghanaian women in order to improve the diagnosis and treatment of this breast cancer subtype. Methods. This retrospective study included 96 women with a morphologically confirmed diagnosis of TNBC who received treatment between 2012 and 2022 at Peace and Love Hospitals (PLH) in Accra and Kumasi (the largest private oncology center in the capital and the second-largest city of Ghana). As a comparison group, to identify the clinical and morphological characteristics of TNBC in Ghanaian women and differences in diagnostic methods, data from 113 women with the same diagnosis who received treatment at the N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, between 2008 and 2015 (Russia) were analyzed. Statistical analysis was performed using the χ² test and Fisher’s exact test; differences were considered significant at p < 0.05. Results. The analysis identified the following clinical and morphological characteristics of TNBC in Ghanaian women. Compared with the comparison group, patients younger than 50 years, premenopausal, with concomitant pathology of the female reproductive system (p=0.05), and with advanced stage III disease – 77% (p=0.02) – predominated. Tumor involvement of the mammary glands was significantly more often accompanied by skin symptoms – 65%, tenderness on palpation – 56.3% (p=0.01); in 46% of cases it was represented by ulcerated tumors with clinical signs of inflammation. In 42% of observations, involvement of the entire mammary gland was noted (p=0.01). Due to limited financial resources, only 29% of women underwent mammography (MG) before treatment initiation, which largely explains the high proportion of patients with advanced-stage disease. Core needle biopsy is of priority importance (p=0.001) for diagnosis and treatment initiation. In Ghanaian patients, TNBC was represented by invasive carcinoma of no special type (p=0.001), grade III malignancy (p=0.01), with a Ki-67 proliferation index > 40% (p=0.01). In the comparative analysis of the morphological characteristics of TNBC, both groups were comparable in the studied parameters (p > 0.05). Conclusions. Clinical and diagnostic characteristics of TNBC were identified in Ghanaian patients compared with the comparison group: a predominance of young premenopausal women, a high frequency of advanced stages and locally advanced forms, and limited access to mammographic diagnostics. No significant morphological differences of this molecular-biological subtype of breast cancer were found between the groups.
- 17 November 2026
- Published by Alfmed LLC in Medical alphabet
- No. 27
A comparative analysis of the key clinical, morphological, and diagnostic characteristics of triple-negative breast cancer in Ghanaian and Russian female populations
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that disproportionately affects women of African descent. In Ghana, the frequency of TNBC is 49%. African-American women with TNBC have worse clinical outcomes than women of European descent. Differences in healthcare systems, access to modern diagnostic and treatment methods, as well as the country of residence at the time of diagnosis, may influence treatment strategy and survival rates. Objective. To analyze the clinical and morphological characteristics of TNBC in Ghanaian women in order to improve the diagnosis and treatment of this breast cancer subtype. Methods. This retrospective study included 96 women with a morphologically confirmed diagnosis of TNBC who received treatment between 2012 and 2022 at Peace and Love Hospitals (PLH) in Accra and Kumasi (the largest private oncology center in the capital and the second-largest city of Ghana). As a comparison group, to identify the clinical and morphological characteristics of TNBC in Ghanaian women and differences in diagnostic methods, data from 113 women with the same diagnosis who received treatment at the N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, between 2008 and 2015 (Russia) were analyzed. Statistical analysis was performed using the χ² test and Fisher’s exact test; differences were considered significant at p < 0.05. Results. The analysis identified the following clinical and morphological characteristics of TNBC in Ghanaian women. Compared with the comparison group, patients younger than 50 years, premenopausal, with concomitant pathology of the female reproductive system (p=0.05), and with advanced stage III disease – 77% (p=0.02) – predominated. Tumor involvement of the mammary glands was significantly more often accompanied by skin symptoms – 65%, tenderness on palpation – 56.3% (p=0.01); in 46% of cases it was represented by ulcerated tumors with clinical signs of inflammation. In 42% of observations, involvement of the entire mammary gland was noted (p=0.01). Due to limited financial resources, only 29% of women underwent mammography (MG) before treatment initiation, which largely explains the high proportion of patients with advanced-stage disease. Core needle biopsy is of priority importance (p=0.001) for diagnosis and treatment initiation. In Ghanaian patients, TNBC was represented by invasive carcinoma of no special type (p=0.001), grade III malignancy (p=0.01), with a Ki-67 proliferation index > 40% (p=0.01). In the comparative analysis of the morphological characteristics of TNBC, both groups were comparable in the studied parameters (p > 0.05). Conclusions. Clinical and diagnostic characteristics of TNBC were identified in Ghanaian patients compared with the comparison group: a predominance of young premenopausal women, a high frequency of advanced stages and locally advanced forms, and limited access to mammographic diagnostics. No significant morphological differences of this molecular-biological subtype of breast cancer were found between the groups.
- Open Access
- 18 July 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (4) , 187-194
Effectiveness of multimodal medical rehabilitation program in a patient with esophageal cancer, severe metabolic disturbances, and functional deficiency: A case report
BACKGROUND: Following neoadjuvant chemotherapy (NACT), patients with esophageal cancer may develop severe functional impairments that render radical surgical intervention impossible. We present a clinical case of severe functional deficiency that developed in a patient with esophageal cancer during NACT, necessitating comprehensive medical rehabilitation prior to radical surgical intervention. Case description: A 75-year-old male was diagnosed with adenocarcinoma of the distal esophagus, stage cT3N0M0 (stage II). He received four cycles of antitumor therapy using the FLOT regimen (fluorouracil, calcium folinate, oxaliplatin, docetaxel), with a positive response. Radical surgical treatment was indicated; however, severe functional decline combined with metabolic disturbances precluded the procedure. A multimodal medical rehabilitation program, including therapeutic exercise, limb massage, nutritional support, and correction of metabolic and fluid-electrolyte imbalances, enabled clinical stabilization of patient within a short period. CONCLUSION: Given the multifaceted nature of functional impairments in patients with esophageal cancer, medical rehabilitation should be based on multimodal programs incorporating symptomatic drug therapy. This approach appears to be optimal in this patient cohort.
- 18 July 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (4) , 187-194
Open AccessEffectiveness of multimodal medical rehabilitation program in a patient with esophageal cancer, severe metabolic disturbances, and functional deficiency: A case report
BACKGROUND: Following neoadjuvant chemotherapy (NACT), patients with esophageal cancer may develop severe functional impairments that render radical surgical intervention impossible. We present a clinical case of severe functional deficiency that developed in a patient with esophageal cancer during NACT, necessitating comprehensive medical rehabilitation prior to radical surgical intervention. Case description: A 75-year-old male was diagnosed with adenocarcinoma of the distal esophagus, stage cT3N0M0 (stage II). He received four cycles of antitumor therapy using the FLOT regimen (fluorouracil, calcium folinate, oxaliplatin, docetaxel), with a positive response. Radical surgical treatment was indicated; however, severe functional decline combined with metabolic disturbances precluded the procedure. A multimodal medical rehabilitation program, including therapeutic exercise, limb massage, nutritional support, and correction of metabolic and fluid-electrolyte imbalances, enabled clinical stabilization of patient within a short period. CONCLUSION: Given the multifaceted nature of functional impairments in patients with esophageal cancer, medical rehabilitation should be based on multimodal programs incorporating symptomatic drug therapy. This approach appears to be optimal in this patient cohort.
- Open Access
- 3 September 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (3) , 233-242
Nutritional deficiency in patients with newly diagnosed diffuse large B-cell lymphoma Prevalence and approaches to correction
Background. Assessing nutritional status at the start of treatment for patients with diffuse large B-cell lymphoma allows us to plan adequate accompanying treatment for patients in whom early nutritional support can improve the results of antitumor treatment.Aim. To assess the prevalence of nutritional deficiency, features of usual diet energy and protein composition in patients with diffuse large B-cell lymphoma who are starting antitumor treatment.Materials and methods. The study included 96 adult patients (m = 61), average age 38.9 ± 16.8 years, with newly diagnosed diffuse large B-cell lymphoma of various localization and prevalence. Additional laboratory screening (total protein, albumin, C-reactive protein (CRP), total cholesterol, triglycerides, daily urea excretion), anthropometric measurements (height, body weight (BW), weight loss over 6 months, body mass index), questionnaire (considering the intake of nutrients during the previous 3 days, calculating the intake of protein and energy, nitrogen balance) were performed in all patients before the first course of antitumor treatment. GLIM (Global Leadership Initiative on Malnutrition) criteria were used to diagnose protein-energy malnutrition (PEM).Results. In studied patients, energy intake was 27.92 ± 6.47 kcal/kg BW per day, protein 0.91 ± 0.18 g/kg BW per day, and nitrogen balance was –3.57 ± 2.94 g/day. Moderate PEM was diagnosed in 37 (38.5 %) patients. Differences in some laboratory parameters were revealed in patients with PEM and without nutritional disorders: CRP level (20.38 ± 14.69 mg/L versus 12.52 ± 5.66 mg/L; p = 0.0004), glucose (5.07 ± 1.09 mmol/L versus 4.57 ± 0.62 mmol/L; p = 0.005), total cholesterol (4.35 ± 1.27 mmol/L versus 5.36 ± 1.45 mmol/L), triglycerides (1.22 ± 0.51 mmol/L versus 2.02 ± 0.78 mmol/L; p = 0.001).Conclusion. Moderate PEM is detected in more than a third of patients with diffuse large B-cell lymphoma who begin antitumor treatment. The leading symptom in this case is unintentional weight loss over the past 6 months. An increased CRP level, moderate hyperglycemia, and lower concentrations of total cholesterol and blood triglycerides also characterize PEM in this cohort of patients. With sufficient energy supply, the amount of protein in the natural diet of patients with PEM turned out to be low, and the nitrogen balance was negative, which in the future can lead to the development of sarcopenia and requires nutritional support.
- 3 September 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (3) , 233-242
Open AccessNutritional deficiency in patients with newly diagnosed diffuse large B-cell lymphoma Prevalence and approaches to correction
Background. Assessing nutritional status at the start of treatment for patients with diffuse large B-cell lymphoma allows us to plan adequate accompanying treatment for patients in whom early nutritional support can improve the results of antitumor treatment.Aim. To assess the prevalence of nutritional deficiency, features of usual diet energy and protein composition in patients with diffuse large B-cell lymphoma who are starting antitumor treatment.Materials and methods. The study included 96 adult patients (m = 61), average age 38.9 ± 16.8 years, with newly diagnosed diffuse large B-cell lymphoma of various localization and prevalence. Additional laboratory screening (total protein, albumin, C-reactive protein (CRP), total cholesterol, triglycerides, daily urea excretion), anthropometric measurements (height, body weight (BW), weight loss over 6 months, body mass index), questionnaire (considering the intake of nutrients during the previous 3 days, calculating the intake of protein and energy, nitrogen balance) were performed in all patients before the first course of antitumor treatment. GLIM (Global Leadership Initiative on Malnutrition) criteria were used to diagnose protein-energy malnutrition (PEM).Results. In studied patients, energy intake was 27.92 ± 6.47 kcal/kg BW per day, protein 0.91 ± 0.18 g/kg BW per day, and nitrogen balance was –3.57 ± 2.94 g/day. Moderate PEM was diagnosed in 37 (38.5 %) patients. Differences in some laboratory parameters were revealed in patients with PEM and without nutritional disorders: CRP level (20.38 ± 14.69 mg/L versus 12.52 ± 5.66 mg/L; p = 0.0004), glucose (5.07 ± 1.09 mmol/L versus 4.57 ± 0.62 mmol/L; p = 0.005), total cholesterol (4.35 ± 1.27 mmol/L versus 5.36 ± 1.45 mmol/L), triglycerides (1.22 ± 0.51 mmol/L versus 2.02 ± 0.78 mmol/L; p = 0.001).Conclusion. Moderate PEM is detected in more than a third of patients with diffuse large B-cell lymphoma who begin antitumor treatment. The leading symptom in this case is unintentional weight loss over the past 6 months. An increased CRP level, moderate hyperglycemia, and lower concentrations of total cholesterol and blood triglycerides also characterize PEM in this cohort of patients. With sufficient energy supply, the amount of protein in the natural diet of patients with PEM turned out to be low, and the nitrogen balance was negative, which in the future can lead to the development of sarcopenia and requires nutritional support.
- Open Access
- 21 February 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (4) , 532-539
Correction of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report
Lymphedema is the tissue fluid accumulation that arises as a consequence of impaired lymphatic drainage. Secondary lower limb lymphedema after surgery in cervical cancer is a result of combined antitumor treatment and significantly reduces the quality of life. The management of lymphedema by physical therapists usually includes a combination of skin care, physiotherapy, external pressure, exercise, and massage. This case report describes the course of treatment for a 53-year-old female with stages IIIB secondary lymphedema. The goal of physical therapy intervention was as restoration of the functionality of the affected lower limb. The rehabilitation tasks were as to reduce total limb volume, return of the stereotype of gait, decrease in the level of anxiety. Decongestive lymphedema therapy was effective in treating this patient with secondary lymphedema of the lower extremities. Although the goal of rehabilitation was partially achieved, the patient was discharged from the hospital in a good mood, her anxiety level decreased, her gait stereotype improved, and her endurance increased. Improving the functionality of the limb, improving its appearance had a positive impact on the quality of life and allowed her to return to work. This case report testifies to the effectiveness of complete decongestive therapy even in the case of severe lymphedema. The clinical result of such rehabilitation programs makes it possible to increase the adaptive potential and social independence of cancer patients.
- 21 February 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (4) , 532-539
Open AccessCorrection of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report
Lymphedema is the tissue fluid accumulation that arises as a consequence of impaired lymphatic drainage. Secondary lower limb lymphedema after surgery in cervical cancer is a result of combined antitumor treatment and significantly reduces the quality of life. The management of lymphedema by physical therapists usually includes a combination of skin care, physiotherapy, external pressure, exercise, and massage. This case report describes the course of treatment for a 53-year-old female with stages IIIB secondary lymphedema. The goal of physical therapy intervention was as restoration of the functionality of the affected lower limb. The rehabilitation tasks were as to reduce total limb volume, return of the stereotype of gait, decrease in the level of anxiety. Decongestive lymphedema therapy was effective in treating this patient with secondary lymphedema of the lower extremities. Although the goal of rehabilitation was partially achieved, the patient was discharged from the hospital in a good mood, her anxiety level decreased, her gait stereotype improved, and her endurance increased. Improving the functionality of the limb, improving its appearance had a positive impact on the quality of life and allowed her to return to work. This case report testifies to the effectiveness of complete decongestive therapy even in the case of severe lymphedema. The clinical result of such rehabilitation programs makes it possible to increase the adaptive potential and social independence of cancer patients.
- Open Access
- 29 January 2024
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (1) , 5-14
Eating behavior in patients with breast cancer
BACKGROUND: Patients with breast cancer in remission tend to be overweight; however, the global literature has no data on eating disorders in this category of women. AIM: To identify any potential eating disorders and their association with personality traits and emotional condition of women who underwent radical treatment for breast cancer and do not show any disease progression. MATERIALS AND METHODS: Thirty-two women who completed breast cancer treatment and did not show any disease progression in one year were asked to fill in Eating Attitude Test (EAT-26) and Big Five personality test and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Microsoft Excel and Statistica 10.0 were used for statistical data processing. The critical significance level was p 0.05. RESULTS: 81.3% of the patients were overweight. A serious eating disorder was found in one patient. In 15.6% of patients were was evidence of strained relationship food. A statistically significant association was established between Neuroticism and Depression ( r =0.362) and between Agreeableness and Level of anxiety ( r =0.37). No correlation was discovered for the probability of an eating disorder and “level of anxiety/depression.” CONCLUSION: Serious eating disorders seem to be uncharacteristic of patients with breast cancer who have completed the treatment. The following pairs of descriptors were found to be associated: Agreeableness/Anxiety and Neuroticism/Depression.
- 29 January 2024
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (1) , 5-14
Open AccessEating behavior in patients with breast cancer
BACKGROUND: Patients with breast cancer in remission tend to be overweight; however, the global literature has no data on eating disorders in this category of women. AIM: To identify any potential eating disorders and their association with personality traits and emotional condition of women who underwent radical treatment for breast cancer and do not show any disease progression. MATERIALS AND METHODS: Thirty-two women who completed breast cancer treatment and did not show any disease progression in one year were asked to fill in Eating Attitude Test (EAT-26) and Big Five personality test and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Microsoft Excel and Statistica 10.0 were used for statistical data processing. The critical significance level was p 0.05. RESULTS: 81.3% of the patients were overweight. A serious eating disorder was found in one patient. In 15.6% of patients were was evidence of strained relationship food. A statistically significant association was established between Neuroticism and Depression ( r =0.362) and between Agreeableness and Level of anxiety ( r =0.37). No correlation was discovered for the probability of an eating disorder and “level of anxiety/depression.” CONCLUSION: Serious eating disorders seem to be uncharacteristic of patients with breast cancer who have completed the treatment. The following pairs of descriptors were found to be associated: Agreeableness/Anxiety and Neuroticism/Depression.
- Open Access
- 1 November 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 4 (4) , 275-285
Is it necessary to diagnose and correct vitamin D deficiency in malignant neoplasms? Analytical review
BACKGROUND: Although the critical role of vitamin D in mineral homeostasis regulation is widely recognized, the global prevalence of vitamin D deficiency is exceedingly high. The substantial number of population-based studies that examine the correlation between the concentration of circulating vitamin D levels and the risk of developing cancer may be attributed to the growing interest of researchers in this vitamin as a suppressor of proliferating epithelial cells. However, the data collected are contradictory. AIM: To ascertain the necessity of diagnosing and rectifying vitamin D deficiency in cancer patients. MATERIALS AND METHODS: The keywords “vitamin D,” “vitamin D deficiency,” “cancer,” and “survival” were employed to identify publications in the e-Library, PubMed, and ScienceDirect databases from January 2014 to January 2024. Based on the data obtained, an analytical review of the literature was conducted. RESULTS: The global prevalence of vitamin D deficiency, including among cancer patients, is exceedingly high and does not vary by sex, age, or ethnicity. Decreased serum vitamin D levels are linked to an elevated incidence of colorectal cancer, breast cancer, melanoma, prostate, and pancreatic cancer. Addressing vitamin D deficiency helped mitigate the risk of developing breast cancer. Data on the effect of vitamin D deficiency and its correction on patient survival are inconsistent. CONCLUSION: Currently, there is no consensus regarding the impact of vitamin D supplementation on the incidence of diverse malignancies, as well as tumor-specific and overall survival. Additional research is required to address the necessity of diagnosing and correcting vitamin D deficiency.
- 1 November 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 4 (4) , 275-285
Open AccessIs it necessary to diagnose and correct vitamin D deficiency in malignant neoplasms? Analytical review
BACKGROUND: Although the critical role of vitamin D in mineral homeostasis regulation is widely recognized, the global prevalence of vitamin D deficiency is exceedingly high. The substantial number of population-based studies that examine the correlation between the concentration of circulating vitamin D levels and the risk of developing cancer may be attributed to the growing interest of researchers in this vitamin as a suppressor of proliferating epithelial cells. However, the data collected are contradictory. AIM: To ascertain the necessity of diagnosing and rectifying vitamin D deficiency in cancer patients. MATERIALS AND METHODS: The keywords “vitamin D,” “vitamin D deficiency,” “cancer,” and “survival” were employed to identify publications in the e-Library, PubMed, and ScienceDirect databases from January 2014 to January 2024. Based on the data obtained, an analytical review of the literature was conducted. RESULTS: The global prevalence of vitamin D deficiency, including among cancer patients, is exceedingly high and does not vary by sex, age, or ethnicity. Decreased serum vitamin D levels are linked to an elevated incidence of colorectal cancer, breast cancer, melanoma, prostate, and pancreatic cancer. Addressing vitamin D deficiency helped mitigate the risk of developing breast cancer. Data on the effect of vitamin D deficiency and its correction on patient survival are inconsistent. CONCLUSION: Currently, there is no consensus regarding the impact of vitamin D supplementation on the incidence of diverse malignancies, as well as tumor-specific and overall survival. Additional research is required to address the necessity of diagnosing and correcting vitamin D deficiency.